Reference health

B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice

https://doi.org/10.4049/jimmunol.0903009
CiteStamped reference-health badge
53/53 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 53 checked references that resolve
resolves10.4049/jimmunol.176.6.3498
Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells
resolves10.1073/pnas.0709205105
Therapeutic B cell depletion impairs adaptive and autoreactive CD4 <sup>+</sup> T cell activation in mice
resolves10.1111/j.1749-6632.2009.05137.x
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer
resolves10.1016/j.immuni.2008.03.017
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
resolves10.1182/blood-2003-07-2379
RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy
resolves10.1002/ijc.2910290320
Anti‐tumor immunity in b‐lymphocyte‐deprived mice. iii. immunity to primary moloney sarcoma virus‐induced tumors
resolves10.1126/science.2118273
The Role of B Cells for in Vivo T Cell Responses to a Friend Virus-Induced Leukemia
resolves10.1006/clin.1994.1099
Anti-tumor Immune Responses of the Tumor-Bearing Host: The Case for Antibody-Mediated Immunologic Enhancement
resolves10.1038/nm0598-627
B cells inhibit induction of T cell-dependent tumor immunity
resolves10.1002/ijc.21177
Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti-tumor CTL and TH1 cytokine responses by B cells
resolves10.1016/j.ccr.2005.04.026
The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged sword
resolves10.1016/j.ccr.2005.04.014
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
resolves10.1006/scbi.2000.0331
Immunological enhancement of primary tumor development and its prevention
resolves10.4049/jimmunol.121.1.359
Anti-Tumor Immunity in B Lymphocyte-Deprived Mice
resolves10.1007/PL00006672
B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion
resolves10.1097/00007890-199306000-00027
CD4+ AND B LYMPHOCYTES IN TRANSPLANTATION IMMUNITY
resolves10.1158/0008-5472.CAN-05-3766
Inhibitory Effects of B Cells on Antitumor Immunity
resolves10.4049/jimmunol.172.8.4709
B Cell-Dependent TCR Diversification
resolves10.1084/jem.183.5.2165
CD8 T cell memory in B cell-deficient mice.
resolves10.4049/jimmunol.163.9.4894
Influence of Lymphocytes on the Presence and Organization of Dendritic Cell Subsets in the Spleen
resolves10.1084/jem.192.4.475
B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo
resolves10.1111/j.1600-065X.2008.00661.x
Regulatory B cells as inhibitors of immune responses and inflammation
resolves10.1111/j.1600-065X.2008.00646.x
B‐lymphocyte contributions to human autoimmune disease
resolves10.1084/jem.20040119
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
resolves10.4049/jimmunol.174.7.4389
The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice
resolves10.1084/jem.20030590
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
resolves10.1046/j.1365-2567.2001.01213.x
Tumours can act as adjuvants for humoral immunity
resolves10.1038/newbio242148a0
Selection of Successive Tumour Lines for Metastasis
resolves10.1016/S0024-3205(01)01454-0
Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model
resolves10.1046/j.1440-1711.1998.00709.x
Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements
resolves10.1016/0092-8674(94)90169-4
T cell receptor antagonist peptides induce positive selection
resolves10.4049/jimmunol.159.2.952
Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes
resolves10.1046/j.1600-6135.2003.00246.x
Development of a Novel Transgenic Mouse for the Study of Interactions Between CD4 and CD8 T Cells During Graft Rejection
resolves10.2353/ajpath.2006.060205
B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic Sclerosis
resolves10.4049/jimmunol.164.2.916
Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor
resolves10.4049/jimmunol.180.1.361
Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice
resolves10.1002/(SICI)1097-0215(19990924)83:1<107::AID-IJC19>3.0.CO;2-T
High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected against B16 melanoma
resolves10.1158/0008-5472.CAN-06-4494
Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance Process
resolves10.1007/s00262-008-0487-4
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
resolves10.1093/intimm/13.12.1583
Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations
resolves10.4049/jimmunol.180.5.2863
B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in FcγR Effector Functions
resolves10.4049/jimmunol.165.10.5558
A Critical Role for B Cells in the Development of Memory CD4 Cells
resolves10.4049/jimmunol.180.7.4994
Suppression of Proteoglycan-Induced Arthritis by Anti-CD20 B Cell Depletion Therapy Is Mediated by Reduction in Autoantibodies and CD4+ T Cell Reactivity
resolves10.4049/jimmunol.179.2.1369
B Cell Depletion Delays Collagen-Induced Arthritis in Mice: Arthritis Induction Requires Synergy between Humoral and Cell-Mediated Immunity
resolves10.1084/jem.20021290
Costimulation via OX40L Expressed by B Cells Is Sufficient to Determine the Extent of Primary CD4 Cell Expansion and Th2 Cytokine Secretion In Vivo
resolves10.1128/JVI.72.11.9208-9216.1998
Evidence for an Underlying CD4 Helper and CD8 T-Cell Defect in B-Cell-Deficient Mice: Failure To Clear Persistent Virus Infection after Adoptive Immunotherapy with Virus-Specific Memory Cells from μMT/μMT Mice
resolves10.1111/j.0300-9475.2004.01517.x
B‐Lymphocytes Activated by CD40 Ligand Induce an Antigen‐Specific Anti‐Tumour Immune Response by Direct and Indirect Activation of CD8<sup>+</sup> T‐cells
resolves10.4049/jimmunol.179.5.3351
Depletion of B Cells in Murine Lupus: Efficacy and Resistance
resolves10.4049/jimmunol.181.8.5257
CD4 T Cell-Mediated Rejection of Cardiac Allografts in B Cell-Deficient Mice
resolves10.1097/00002371-200407000-00003
Enhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes
resolves10.1097/CJI.0b013e31816d1d6a
B-cell Depletion Using an Anti-CD20 Antibody Augments Antitumor Immune Responses and Immunotherapy in Nonhematopoetic Murine Tumor Models
resolves10.1038/nm1290
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma
resolves10.1016/j.it.2004.09.016
DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy
The 3 references without a DOI — listed, not checked
no DOI — not checkedRegulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.
no DOI — not checkedCharacterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
no DOI — not checkedTissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.4049/jimmunol.0903009"><img src="https://citestamp.com/citestamped/10.4049/jimmunol.0903009/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.4049/jimmunol.0903009/badge.svg)](https://citestamp.com/citestamped/10.4049/jimmunol.0903009)